SCHEMBL19082232

SCHEMBL19082232

c1ccc(-c2c3ccccc3c(-c3ccc(-c4cc5c(sc6ccc7ccccc7c65)c5sc6ccccc6c45)cc3)c3ccccc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 5/20 0.38
NQO2 P16083 2/20 0.36
NQO1 P15559 1/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
PTPRC P08575 1/20 0.34
PTPRF P10586 1/20 0.34
PTPRA P18433 1/20 0.34
PTPRB P23467 1/20 0.34
PTPN6 P29350 1/20 0.34
DUSP3 P51452 1/20 0.34
PTPN12 Q05209 1/20 0.34
CYP1A1 P04798 2/20 0.33
CYP1B1 Q16678 1/20 0.33
TNKS O95271 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082250 0.92 ALOX5 (0.36) PTPN1NQO2NQO1PTPRCPTPRF
SCHEMBL19082333 0.91 PTPN1 (0.36) PTPN1NQO2NQO1KDM4EALDH1A1
SCHEMBL19082194 0.89 PTPN1 (0.37) PTPN1NQO2NQO1KDM4EALDH1A1
SCHEMBL19082314 0.89 ALOX5 (0.35) PTPN1NQO2NQO1PTPRCPTPRF
SCHEMBL17932223 0.86 TNKS (0.43) PTPN1KDM4EALDH1A1MAPTPTPRC
SCHEMBL19082386 0.85 ALOX5 (0.37) PTPN1NQO2NQO1ALOX5MAP3K9
SCHEMBL19082172 0.85 PTPN1 (0.34) PTPN1NQO2NQO1CYP1A1CYP1B1
SCHEMBL19082229 0.84 NQO2 (0.36) PTPN1NQO2NQO1KDM4EMAPT
SCHEMBL19082242 0.84 TNKS (0.40) PTPN1NQO2NQO1KDM4EALDH1A1
SCHEMBL19082251 0.83 NQO2 (0.34) PTPN1NQO2NQO1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 PTPN1 4695/4885NQO2 2592/4885NQO1 576/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 PTPN1 4695/4885NQO2 2592/4885NQO1 576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.